ArticleFrontiers in immunology2024

Efficacy and safety of PD-1 inhibitors plus chemotherapy with or without endostatin for stage IV lung squamous cancer: a retrospective study.

Chengliu Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.